
Denmark’s second-largest pharmaceutical company, Lundbeck, has lowered its expectations for operating results in 2013 and 2014 significantly, the company announces in a stock market release.
The news about the updated expectations sees the company share dipping by 16.5 % as of Wednesday morning.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app